![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 49, 49342-49347, December 5, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrin-Ligand Interactions*

¶
**




From the
McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, Wisconsin 53706, and
Department of Microbiology, Immunology, and Molecular Genetics, University of California at Los Angeles, Los Angeles, California 90095, and ||Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada
The secreted protein toxin produced by Bacillus anthracis contributes to virulence of this pathogen and can cause many of the symptoms seen during an anthrax infection, including shock and sudden death. The cellbinding component of anthrax toxin, protective antigen, mediates entry of the toxin into cells by first binding directly to the extracellular integrin-like inserted (I) domain of the cellular anthrax toxin receptor, ATR. Here we report that this interaction requires an intact metal ion-dependent adhesion site (MIDAS) in the receptor as well as the presence of specific divalent cations. Also, we demonstrate that the toxin-receptor interaction is critically dependent on the Asp-683 carboxylate group of protective antigen, which projects from the receptor binding surface. We propose that this carboxylate group completes the coordination of the MIDAS metal of ATR, mimicking integrin-ligand interactions.
Received for publication, July 21, 2003 , and in revised form, September 16, 2003.
* This work was supported in part by Grant AI48489 from the National Institutes of Health (to J. A. T. Y.). Flow cytometry was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility, which is supported by National Institutes of Health Awards CA-16042 and AI-28697, by the JCCC, the UCLA AIDS Institute, and the Geffen School of Medicine at UCLA. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** Supported by Training in Oncology Grant T32 CA09075.

Present address: Infectious Disease Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, 92037.
¶ To whom correspondence should be addressed: Dept. of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, 609 Charles E. Young Dr. East, Los Angeles, CA 90095. Tel.: 310-206-7465; Fax: 310-206-5231; E-mail: kbradley{at}microbio.ucla.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H.-F. Duan, X.-W. Hu, J.-L. Chen, L.-H. Gao, Y.-Y. Xi, Y. Lu, J.-F. Li, S.-R. Zhao, J.-J. Xu, H.-P. Chen, et al. Antitumor Activities of TEM8-Fc: An Engineered Antibody-like Molecule Targeting Tumor Endothelial Marker 8 J Natl Cancer Inst, October 17, 2007; 99(20): 1551 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Rogers, K. A. Christensen, A. E. Birsner, S. M. Short, D. J. Wigelsworth, R. J. Collier, and R. J. D'Amato Mutant Anthrax Toxin B Moiety (Protective Antigen) Inhibits Angiogenesis and Tumor Growth Cancer Res., October 15, 2007; 67(20): 9980 - 9985. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Basha, P. Rai, V. Poon, A. Saraph, K. Gujraty, M. Y. Go, S. Sadacharan, M. Frost, J. Mogridge, and R. S. Kane Polyvalent inhibitors of anthrax toxin that target host receptors PNAS, September 5, 2006; 103(36): 13509 - 13513. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Werner, A. P. Kowalczyk, and V. Faundez Anthrax Toxin Receptor 1/Tumor Endothelium Marker 8 Mediates Cell Spreading by Coupling Extracellular Ligands to the Actin Cytoskeleton J. Biol. Chem., August 11, 2006; 281(32): 23227 - 23236. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gao and K. Schulten Onset of Anthrax Toxin Pore Formation Biophys. J., May 1, 2006; 90(9): 3267 - 3279. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Kocer, S. G. Walker, B. Zerler, L. M. Golub, and S. R. Simon Metalloproteinase Inhibitors, Nonantimicrobial Chemically Modified Tetracyclines, and Ilomastat Block Bacillus anthracis Lethal Factor Activity in Viable Cells Infect. Immun., November 1, 2005; 73(11): 7548 - 7557. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. A. Rainey, D. J. Wigelsworth, P. L. Ryan, H. M. Scobie, R. J. Collier, and J. A. T. Young Receptor-specific requirements for anthrax toxin delivery into cells PNAS, September 13, 2005; 102(37): 13278 - 13283. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bonuccelli, F. Sotgia, P. G. Frank, T. M. Williams, C. J. de Almeida, H. B. Tanowitz, P. E. Scherer, K. A. Hotchkiss, B. I. Terman, B. Rollman, et al. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1402 - C1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Lacy, D. J. Wigelsworth, R. A. Melnyk, S. C. Harrison, and R. J. Collier Structure of heptameric protective antigen bound to an anthrax toxin receptor: A role for receptor in pH-dependent pore formation PNAS, September 7, 2004; 101(36): 13147 - 13151. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Barth, K. Aktories, M. R. Popoff, and B. G. Stiles Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins Microbiol. Mol. Biol. Rev., September 1, 2004; 68(3): 373 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Wigelsworth, B. A. Krantz, K. A. Christensen, D. B. Lacy, S. J. Juris, and R. J. Collier Binding Stoichiometry and Kinetics of the Interaction of a Human Anthrax Toxin Receptor, CMG2, with Protective Antigen J. Biol. Chem., May 28, 2004; 279(22): 23349 - 23356. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Lacy, D. J. Wigelsworth, H. M. Scobie, J. A. T. Young, and R. J. Collier Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: An anthrax toxin receptor PNAS, April 27, 2004; 101(17): 6367 - 6372. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |